NEW TB VACCINES NEEDED TO TACKLE AMR
In a new brief, the TB Vaccine Advocacy Roadmap (TB Vax ARM) coalition draws on the latest research in health and economic modelling to demonstrate how new TB vaccines could significantly help control drug-resistant TB, in a cost-effective and affordable way. This brief shares a collective call to decision-makers to prioritize TB vaccine research and development (R&D) as a signature piece of global health and AMR agendas. TB vaccines remain neglected in the AMR agenda despite the World Health Organization calling for the highest priority action on TB vaccine development to prevent AMR.
OUR UNDERWRITERS
Unrestricted financial support by:
 |
LifeArc |
 |
Antimicrobial Resistance Fighter Coalition |
 |
Bangalore Bioinnovation Centre |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
AMR NEWS
Every two weeks in your inbox
Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!